Mwita Julius C, Ogunleye Olayinka O, Olalekan Adesola, Kalungia Aubrey C, Kurdi Amanj, Saleem Zikria, Sneddon Jacqueline, Godman Brian
Department of Internal Medicine, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Department of Pharmacology, Therapeutics and Toxicology, Lagos State University College of Medicine, Lagos, Nigeria.
Int J Gen Med. 2021 Feb 18;14:515-530. doi: 10.2147/IJGM.S253216. eCollection 2021.
There is a concern with the growing use of antimicrobials across countries increasing antimicrobial resistance (AMR) rates. A key area within hospitals is their use for the prevention of surgical site infections (SSI) with concerns with timing of the first dose, which can appreciably impact on effectiveness, as well as duration with extended prophylaxis common among low- and middle-income countries (LMICs). This is a concern as extended duration increases utilization rates and AMR as well as adverse events. Consequently, there is a need to document issues of timing and duration of surgical antibiotic prophylaxis (SAP) among LMICs together with potential ways forward to address current concerns.
Narrative review of timings and duration of SAP among LMICs combined with publications documenting successful approaches to improve SAP to provide future direction to all key stakeholder groups.
There were documented concerns with the timing of the first dose of antibiotics, with appropriate timing as low as 6.7% in Egypt, although as high as 81.9% in Turkey. There was also an extensive duration of SAP, ranging from long duration times in all patients in a study in Nigeria with a mean of 8.7 days and 97% of patients in Egypt to 42.9% of patients in Pakistan and 35% in Turkey. Successful interventions to improve SAP typically involved multiple approaches including education of all key stakeholder groups, monitoring of usage against agreed guidelines,as well as quality targets. Multiple approaches typically improved timing and duration as well as reduced costs. For instance, in one study appropriateness increased from 30.1% to 91.4%, prolonged duration reduced to 5.7% of patients, and mean costs of antibiotics decreased 11-fold.
There are considerable concerns with the timing and duration of SAP among LMICs. Multiple interventions among LMICs can address this providing future directions.
随着各国抗菌药物使用的增加,抗菌药物耐药性(AMR)发生率也在上升,这引发了人们的担忧。医院内的一个关键领域是使用抗菌药物预防手术部位感染(SSI),人们关注首剂给药时间,因为这会显著影响疗效,同时也关注低收入和中等收入国家(LMICs)中常见的延长预防用药时间的问题。这令人担忧,因为延长用药时间会增加使用率、AMR以及不良事件的发生。因此,有必要记录LMICs中手术抗生素预防(SAP)的时间和持续时间问题,以及解决当前问题的潜在前进方向。
对LMICs中SAP的时间和持续时间进行叙述性综述,并结合记录成功改善SAP方法的出版物,为所有关键利益相关者群体提供未来方向。
有记录表明人们担心首剂抗生素的给药时间,埃及的适当给药时间低至6.7%,而土耳其高达81.9%。SAP的持续时间也很长,在尼日利亚的一项研究中,所有患者的持续时间都很长,平均为8.7天,埃及97%的患者如此,而在巴基斯坦为42.9%的患者,在土耳其为35%。成功改善SAP的干预措施通常涉及多种方法,包括对所有关键利益相关者群体进行教育、根据商定的指南监测使用情况以及质量目标。多种方法通常能改善时间和持续时间,并降低成本。例如,在一项研究中,适宜性从30.1%提高到91.4%,延长持续时间的患者减少到5.7%,抗生素的平均成本降低了11倍。
LMICs中对SAP的时间和持续时间存在相当大的担忧。LMICs中的多种干预措施可以解决这一问题并提供未来方向。